Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Alex Del Priore, senior vice-president of manufacturing services at Syngene, looks at the role India

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on

Inotiv, a US CRO specialising in nonclinical and analytical drug discovery and development services, has

AlzChem, the only supplier of speciality nitriles outside China, has completed a €12 million expansion

Merck KGaA is to spend €59 million to expand HPAPI and ADC manufacturing capabilities and